Tectonic Therapeutic Inc
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
TECX$21.89+6.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations and Comprehensive Loss
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Operating expenses: | ||||
| Research and development | $7,074 | $8,766 | $17,892 | $21,751 |
| General and administrative | 4,347 | 1,865 | 6,497 | 3,411 |
| Total operating expenses | 11,421 | 10,631 | 24,389 | 25,162 |
| Loss from operations | (11,421) | (10,631) | (24,389) | (25,162) |
| Other (expense) income, net: | ||||
| Change in fair value of SAFE liabilities | (1,535) | — | (3,610) | — |
| Interest income | 318 | 224 | 574 | 352 |
| Interest expense | (28) | (40) | (59) | (82) |
| Other expense | (5) | (8) | (408) | (8) |
| Total other (expense) income, net | (1,250) | 176 | (3,503) | 262 |
| Net loss | (12,671) | (10,455) | (27,892) | (24,900) |
| Net loss per share attributable to common stockholders, basic and diluted | $(4.34) | $(8.51) | $(12.97) | $(20.60) |
| Weighted-average common shares outstanding, basic and diluted | 2,919,872 | 1,228,778 | 2,150,160 | 1,208,447 |
| Other comprehensive loss: | ||||
| Foreign currency translation adjustment | (8) | — | (50) | — |
| Comprehensive loss | $(12,679) | $(10,455) | $(27,942) | $(24,900) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.